MDXG Q3 2019 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$666M

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$89M+2.2% YoY

Gross Profit

$76M85.1% margin

Operating Income

$14M16.0% margin

Net Income

$12M13.9% margin

EPS (Diluted)

$0.11

QoQ Revenue Growth

+31.8%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$179M

Total Liabilities

$140M

Stockholders' Equity

$40M

Cash & Equivalents

$94M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$89M	$87M	+2.2%
Gross Profit	$76M	$80M	-5.0%
Operating Income	$14M	$373,000	+3706.4%
Net Income	$12M	-$178,000	+7054.5%